Valuation: Elanco Animal Health Incorporated

Capitalization 11.81B 10.02B 9.18B 8.66B 16.14B 1,125B 16.27B 109B 42.49B 536B 44.32B 43.39B 1,855B P/E ratio 2026 *
256x
P/E ratio 2027 * 84.6x
Enterprise value 14.8B 12.56B 11.51B 10.85B 20.23B 1,410B 20.4B 136B 53.26B 672B 55.55B 54.38B 2,325B EV / Sales 2026 *
2.93x
EV / Sales 2027 * 2.68x
Free-Float
98.8%
Yield 2026 *
-
Yield 2027 * -
1 day-8.16%
1 week-3.51%
Current month-2.91%
1 month-6.10%
3 months-15.52%
6 months-4.99%
Current year-4.02%
1 week 21.64
Extreme 21.635
26.29
1 month 21.62
Extreme 21.62
26.29
Current year 21.62
Extreme 21.62
27.72
1 year 12.4
Extreme 12.402
27.72
3 years 7.88
Extreme 7.88
27.72
5 years 7.88
Extreme 7.88
37.49
10 years 7.88
Extreme 7.88
37.61
Manager TitleAgeSince
Chief Executive Officer 58 01/07/2018
Director of Finance/CFO 50 07/07/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 58 01/07/2018
Chairman 79 01/05/2018
Director/Board Member 72 01/09/2018
Change 5d. change 1-year change 3-years change Capi.($)
-8.16%-3.51%+81.61%+147.10% 11.81B
-7.44%-31.96%-51.86%-58.58% 34.72B
+1.06%-6.47%+26.84%+52.52% 5.57B
-3.43%-2.90%+15.03%+15.98% 3.59B
+1.46%+4.93%+119.34%+42.15% 2.42B
-0.98%+0.83%-22.97%-8.03% 1.76B
-9.20%-33.58%+61.64%+157.41% 1.62B
+0.95%+0.56%-12.90%-9.73% 1.2B
+1.49%-0.53%+10.00%-45.12% 1.11B
-1.75%-1.88%-0.14%-21.67% 1.03B
Average -1.62%-5.46%+22.66%+27.20% 6.48B
Weighted average by Cap. -0.51%-14.93%-4.46%+4.82%

Financials

2026 *2027 *
Net sales 5.05B 4.28B 3.92B 3.7B 6.9B 481B 6.95B 46.5B 18.15B 229B 18.93B 18.53B 792B 5.31B 4.51B 4.13B 3.89B 7.26B 506B 7.32B 48.97B 19.12B 241B 19.94B 19.52B 834B
Net income 45.06M 38.24M 35.02M 33.02M 61.58M 4.29B 62.08M 415M 162M 2.04B 169M 166M 7.08B 126M 107M 97.92M 92.33M 172M 12B 174M 1.16B 453M 5.72B 473M 463M 19.79B
Net Debt 2.99B 2.54B 2.33B 2.19B 4.09B 285B 4.12B 27.58B 10.77B 136B 11.23B 10.99B 470B 2.45B 2.08B 1.91B 1.8B 3.35B 234B 3.38B 22.62B 8.83B 111B 9.21B 9.01B 385B
Logo Elanco Animal Health Incorporated
Elanco Animal Health Incorporated is an animal health company. The Company is engaged in delivering products and services to prevent and treat disease in farm animals and pets. It serves animals across species, including dogs, cats, cattle, poultry, swine and sheep. Its pet health products help pets live longer, healthier and more active lives. Its pet health portfolio is focused on parasiticides, dermatology, vaccines and pain/other therapeutics. It includes parasiticide portfolios in the pet health market based on indications, species and formulations, with products that protect pets from fleas, ticks and internal parasites. It offers Advantage, K-9 Advantix, Advocate, and AdTab, which are over-the-counter treatments for the prevention and elimination of fleas and ticks. Its farm animal products help producers improve animal health and wellbeing. It offers a farm animal portfolio of products for cattle including beef and dairy, poultry, swine and sheep.
Employees
9,650
Date Price Change Volume
11/05/26 21.72 $ -8.16% 8,236,431
08/05/26 23.65 $ -1.50% 8,287,981
07/05/26 24.01 $ -8.29% 11,810,925
06/05/26 26.18 $ +13.88% 12,365,362
05/05/26 22.99 $ +2.13% 6,295,574
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
21.72USD
Average target price
29.86USD
Spread / Average Target
+37.46%

Quarterly revenue - Rate of surprise